HEADER IMMUNE SYSTEM 27-NOV-18 6N7D TITLE STRUCTURE OF THE HUMAN JAK1 KINASE DOMAIN WITH COMPOUND 54 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 1,JAK-1; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK1, JAK1A, JAK1B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS JAK1, IL13, IL-13, JAK2, JAK3, TYK2, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.J.LUPARDUS,D.BROWN REVDAT 3 23-OCT-24 6N7D 1 REMARK REVDAT 2 15-MAY-19 6N7D 1 JRNL REVDAT 1 24-APR-19 6N7D 0 JRNL AUTH M.ZAK,E.J.HANAN,P.LUPARDUS,D.G.BROWN,C.ROBINSON,M.SIU, JRNL AUTH 2 J.P.LYSSIKATOS,F.A.ROMERO,G.ZHAO,T.KELLAR,R.MENDONCA, JRNL AUTH 3 N.C.RAY,S.C.GOODACRE,P.H.CRACKETT,N.MCLEAN,C.A.HURLEY, JRNL AUTH 4 P.W.YUEN,Y.X.CHENG,X.LIU,M.LIIMATTA,P.B.KOHLI,J.NONOMIYA, JRNL AUTH 5 G.SALMON,G.BUCKLEY,J.LLOYD,P.GIBBONS,N.GHILARDI,J.R.KENNY, JRNL AUTH 6 A.JOHNSON JRNL TITL DISCOVERY OF A CLASS OF HIGHLY POTENT JANUS KINASE 1/2 JRNL TITL 2 (JAK1/2) INHIBITORS DEMONSTRATING EFFECTIVE CELL-BASED JRNL TITL 3 BLOCKADE OF IL-13 SIGNALING. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 1522 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30981576 JRNL DOI 10.1016/J.BMCL.2019.04.008 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 32149 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1617 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2875 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2502 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2714 REMARK 3 BIN R VALUE (WORKING SET) : 0.2485 REMARK 3 BIN FREE R VALUE : 0.2784 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2263 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 227 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.88 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.87660 REMARK 3 B22 (A**2) : -5.32150 REMARK 3 B33 (A**2) : 1.44490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.121 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.118 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2360 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3189 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 826 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 423 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2360 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 290 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2857 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.34 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.57 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6N7D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238014. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAY-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32216 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 38.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.62800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 5-6 AND 25-35% PEG 6000, REMARK 280 PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 84.99500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.32500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 84.99500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 21.32500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1471 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 853 REMARK 465 ASP A 854 REMARK 465 ILE A 855 REMARK 465 VAL A 856 REMARK 465 SER A 857 REMARK 465 GLU A 858 REMARK 465 LYS A 859 REMARK 465 LYS A 860 REMARK 465 PRO A 861 REMARK 465 ALA A 862 REMARK 465 THR A 863 REMARK 465 GLU A 864 REMARK 465 GLU A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLY A 916 REMARK 465 ASN A 917 REMARK 465 GLU A 946 REMARK 465 ASP A 947 REMARK 465 GLY A 948 REMARK 465 GLY A 949 REMARK 465 ASN A 950 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A1031 CG OD1 OD2 REMARK 470 GLU A1033 CG CD OE1 OE2 REMARK 470 LYS A1038 CG CD CE NZ REMARK 470 LYS A1057 CG CD CE NZ REMARK 470 LYS A1154 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 895 71.39 -115.87 REMARK 500 ASP A1003 34.28 -147.21 REMARK 500 PRO A1136 18.55 -64.32 REMARK 500 THR A1140 172.71 -50.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KF4 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1202 DBREF 6N7D A 854 1154 UNP P23458 JAK1_HUMAN 854 1154 SEQADV 6N7D GLY A 853 UNP P23458 EXPRESSION TAG SEQRES 1 A 302 GLY ASP ILE VAL SER GLU LYS LYS PRO ALA THR GLU VAL SEQRES 2 A 302 ASP PRO THR HIS PHE GLU LYS ARG PHE LEU LYS ARG ILE SEQRES 3 A 302 ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL GLU LEU SEQRES 4 A 302 CYS ARG TYR ASP PRO GLU GLY ASP ASN THR GLY GLU GLN SEQRES 5 A 302 VAL ALA VAL LYS SER LEU LYS PRO GLU SER GLY GLY ASN SEQRES 6 A 302 HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU ILE LEU ARG SEQRES 7 A 302 ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR LYS GLY ILE SEQRES 8 A 302 CYS THR GLU ASP GLY GLY ASN GLY ILE LYS LEU ILE MET SEQRES 9 A 302 GLU PHE LEU PRO SER GLY SER LEU LYS GLU TYR LEU PRO SEQRES 10 A 302 LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN GLN LEU LYS SEQRES 11 A 302 TYR ALA VAL GLN ILE CYS LYS GLY MET ASP TYR LEU GLY SEQRES 12 A 302 SER ARG GLN TYR VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 13 A 302 VAL LEU VAL GLU SER GLU HIS GLN VAL LYS ILE GLY ASP SEQRES 14 A 302 PHE GLY LEU THR LYS ALA ILE GLU THR ASP LYS GLU PTR SEQRES 15 A 302 PTR THR VAL LYS ASP ASP ARG ASP SER PRO VAL PHE TRP SEQRES 16 A 302 TYR ALA PRO GLU CYS LEU MET GLN SER LYS PHE TYR ILE SEQRES 17 A 302 ALA SER ASP VAL TRP SER PHE GLY VAL THR LEU HIS GLU SEQRES 18 A 302 LEU LEU THR TYR CYS ASP SER ASP SER SER PRO MET ALA SEQRES 19 A 302 LEU PHE LEU LYS MET ILE GLY PRO THR HIS GLY GLN MET SEQRES 20 A 302 THR VAL THR ARG LEU VAL ASN THR LEU LYS GLU GLY LYS SEQRES 21 A 302 ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP GLU VAL TYR SEQRES 22 A 302 GLN LEU MET ARG LYS CYS TRP GLU PHE GLN PRO SER ASN SEQRES 23 A 302 ARG THR SER PHE GLN ASN LEU ILE GLU GLY PHE GLU ALA SEQRES 24 A 302 LEU LEU LYS MODRES 6N7D PTR A 1034 TYR MODIFIED RESIDUE MODRES 6N7D PTR A 1035 TYR MODIFIED RESIDUE HET PTR A1034 16 HET PTR A1035 16 HET KF4 A1201 28 HET GOL A1202 6 HETNAM PTR O-PHOSPHOTYROSINE HETNAM KF4 N-[5-(6-METHOXY-1H-INDAZOL-5-YL)-1H-PYRAZOL-4- HETNAM 2 KF4 YL]PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 KF4 C18 H14 N8 O2 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *227(H2 O) HELIX 1 AA1 GLU A 871 ARG A 873 5 3 HELIX 2 AA2 ILE A 919 ASN A 931 1 13 HELIX 3 AA3 SER A 963 ASN A 971 1 9 HELIX 4 AA4 ASN A 976 ARG A 997 1 22 HELIX 5 AA5 ALA A 1005 ARG A 1007 5 3 HELIX 6 AA6 PRO A 1044 TYR A 1048 5 5 HELIX 7 AA7 ALA A 1049 SER A 1056 1 8 HELIX 8 AA8 ILE A 1060 THR A 1076 1 17 HELIX 9 AA9 ASP A 1079 SER A 1082 5 4 HELIX 10 AB1 SER A 1083 GLY A 1093 1 11 HELIX 11 AB2 HIS A 1096 GLN A 1098 5 3 HELIX 12 AB3 MET A 1099 GLU A 1110 1 12 HELIX 13 AB4 PRO A 1121 TRP A 1132 1 12 HELIX 14 AB5 SER A 1141 LYS A 1154 1 14 SHEET 1 AA1 5 LEU A 875 GLU A 883 0 SHEET 2 AA1 5 GLY A 887 TYR A 894 -1 O LEU A 891 N ILE A 878 SHEET 3 AA1 5 GLU A 903 LEU A 910 -1 O GLU A 903 N TYR A 894 SHEET 4 AA1 5 LYS A 953 GLU A 957 -1 O MET A 956 N ALA A 906 SHEET 5 AA1 5 TYR A 940 CYS A 944 -1 N GLY A 942 O ILE A 955 SHEET 1 AA2 2 TYR A 999 VAL A1000 0 SHEET 2 AA2 2 LYS A1026 ALA A1027 -1 O LYS A1026 N VAL A1000 SHEET 1 AA3 2 VAL A1009 SER A1013 0 SHEET 2 AA3 2 GLN A1016 ILE A1019 -1 O LYS A1018 N LEU A1010 SHEET 1 AA4 2 PTR A1034 THR A1036 0 SHEET 2 AA4 2 LYS A1057 TYR A1059 -1 O PHE A1058 N PTR A1035 LINK C GLU A1033 N PTR A1034 1555 1555 1.37 LINK C PTR A1034 N PTR A1035 1555 1555 1.39 LINK C PTR A1035 N THR A1036 1555 1555 1.34 SITE 1 AC1 17 LEU A 881 GLY A 882 VAL A 889 ALA A 906 SITE 2 AC1 17 MET A 956 GLU A 957 LEU A 959 GLY A 962 SITE 3 AC1 17 GLU A 966 LEU A1010 GLY A1020 ASP A1021 SITE 4 AC1 17 GOL A1202 HOH A1317 HOH A1346 HOH A1375 SITE 5 AC1 17 HOH A1446 SITE 1 AC2 5 GLU A 883 ARG A1007 ASN A1008 KF4 A1201 SITE 2 AC2 5 HOH A1317 CRYST1 169.990 42.650 44.890 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005883 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023447 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022277 0.00000